Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Endpoints in COPD with Salmeterol/Fluticasone
NCT00358358Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 4 trial of fluticasone propionate, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00358358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358358.